Egalet Corporation announced that Paul C. Varki, J.D., M.P.H, joins Egalet as senior vice president and general counsel effective immediately. Mr. Varki will report to Bob Radie, president and chief executive officer. Mr. Varki joins Egalet from GlaxoSmithKline (GSK) where he had been assistant general counsel since 2011, providing global legal support for research and development.

Prior to that role he served as senior counsel for the vaccines business unit within North America and counsel for marketed products within the U.S. pharmaceuticals business.